The Asia Pacific Refractive Surgery Devices Market would witness market growth of 10.8% CAGR during the forecast period (2021-2027).
These surgeries help people in becoming independent by reducing or removing the use of contact lenses or spectacles. Throughout the pandemic, people managed their preferences and started spending less on their personal products and more on such products that are beneficial for their health and wellbeing, due to which the demand for refractive surgery devices was propelled. In contrast, the emerging nations are experiencing a shortage of surgical devices for correcting refractive errors, which is responsible for hampering the growth of the refractive surgery devices market.
Several surgery devices and equipment companies are shifting their focus on advancing the technologies involved in the field of refractive surgery. The latest technologies utilized for correcting refractive errors help in decreasing the time taken while performing surgeries, increasing the scale of the treatment, and also reducing the labor cost. The refractive surgery devices market would augment by the introduction of the latest corneal refractive surgical techniques like pseudophakic intraocular lenses, corneal stiffening techniques like collagen crosslinking, intraocular rings & segments, and femtosecond corneal surgery techniques. In addition, the latest femtosecond laser surgical devices offer several unique features like depth and edge angle, fast flap creation, and complete surgical control down to the micron in terms of diameter.
Asia-Pacific refractive surgery devices market is one of the major growing sectors in the medical devices industry with the growing demand for better quality healthcare services to enhance the lives of millions. Refractive surgery devices are commonly used to treat eye problems like myopia, hyperopia, presbyopia, or astigmatism. The utilization of refractive surgery devices in surgeries helps in decreasing the time taken during the treatment.
In addition, it is anticipated that the regional market will grow at a rapid pace in the upcoming years. There is a rise in investments by key players in developing markets due to the surging demand for better healthcare facilities. In addition, a rapid increase in the geriatric population across this region is likely to augment the growth of the refractive surgery devices market.
The China market dominated the Asia Pacific Aberrometers Market by Country in 2020, and would continue to be a dominant market till 2027; thereby, achieving a market value of $5,787 Thousands by 2027. The Japan market is showcasing a CAGR of 11.3% during (2021 - 2027). Additionally, The India market is poised to grow at a CAGR of 11.2% during (2021 - 2027).
Based on Application, the market is segmented into Astigmatism, Myopia, Hyperopia, Presbyopia, and Dry eyes. Based on Product, the market is segmented into Lasers, Microkeratome, Aberrometers and Other Products. Based on End Use, the market is segmented into Ophthalmology Clinics, Hospitals and Ambulatory surgery centers. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Refractive Surgery Devices Market is Projected to reach USD 331.5 million by 2027, at a CAGR of 9.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Carl Zeiss Meditec AG, Topcon Corporation, Novartis AG, Glaukos Corporation, Johnson & Johnson, Essilorluxottica SA, Bausch Health Companies, Inc., SCHWIND Eye-Tech-Solutions GmbH, NIDEK CO., LTD., and Quantel Medical (Lumibird Group).
By Application
By Product
By End Use
By Country
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 